These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9453443)

  • 1. Insulin-like growth factor-I in liver cirrhosis.
    Blomsma MC; de Knegt RJ; Dullaart RP; Jansen PL
    J Hepatol; 1997 Dec; 27(6):1133-8. PubMed ID: 9453443
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth factors and malnutrition in chronic renal failure.
    Fouque DP; Laville M
    Adv Nephrol Necker Hosp; 1998; 28():259-85. PubMed ID: 9889994
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of parenteral nutrition without and with growth hormone on growth hormone/insulin-like growth factor-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis.
    Cao J; Luo SM; Liang L; Lai J
    JPEN J Parenter Enteral Nutr; 2007; 31(6):496-501. PubMed ID: 17947606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human growth hormone but not human insulin-like growth factor-I enhances recovery from neonatal malnutrition in rats.
    Zhao X; Unterman TG; Donovan SM
    J Nutr; 1995 May; 125(5):1316-27. PubMed ID: 7537807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis.
    Assy N; Hochberg Z; Amit T; Shen-Orr Z; Enat R; Baruch Y
    J Hepatol; 1997 Nov; 27(5):796-802. PubMed ID: 9382965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral supplement of BCAA in patients with liver disease].
    Yoshida S; Ishibashi N; Tajiri T; Muraoka T; Tanaka K; Shirouzu K
    Nihon Rinsho; 2001 May; 59 Suppl 5():293-6. PubMed ID: 11439540
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose and insulin metabolism in cirrhosis.
    Record CO
    Adv Exp Med Biol; 1997; 420():229-33. PubMed ID: 9286437
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease.
    Scharf JG; Schmitz F; Frystyk J; Skjaerbaek C; Moesus H; Blum WF; Ramadori G; Hartmann H
    J Hepatol; 1996 Nov; 25(5):689-99. PubMed ID: 8938547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to growth hormone in children with chronic liver disease.
    Bucuvalas JC; Horn JA; Chernausek SD
    Pediatr Transplant; 1997 Aug; 1(1):73-9. PubMed ID: 10084790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of insulin-like growth factor-I: a focus on insulin sensitivity.
    Hussain MA; Schmitz O; Christiansen JS; Zapf J; Froesch ER
    Metabolism; 1995 Oct; 44(10 Suppl 4):108-12. PubMed ID: 7476302
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose metabolism and liver cirrhosis.
    Nolte W; Hartmann H; Ramadori G
    Exp Clin Endocrinol Diabetes; 1995; 103(2):63-74. PubMed ID: 7553077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between glucocorticoids and growth hormone.
    Mehls O; Tönshoff B; Kovàcs G; Mayer C; Schurek J; Oh J
    Acta Paediatr Suppl; 1993 Mar; 388():77-82. PubMed ID: 8329835
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of exogenous growth hormone and insulin-like growth factor I in malnutrition and acute metabolic stress: a hypothesis.
    Chwals WJ; Bistrian BR
    Crit Care Med; 1991 Oct; 19(10):1317-22. PubMed ID: 1914490
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis.
    Assy N; Hochberg Z; Enat R; Baruch Y
    Dig Dis Sci; 1998 Jun; 43(6):1317-21. PubMed ID: 9635625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis.
    Kratzsch J; Blum WF; Schenker E; Keller E
    Exp Clin Endocrinol Diabetes; 1995; 103(5):285-91. PubMed ID: 8536056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver.
    Takahashi Y
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic renal failure].
    Okuno S; Inaba M
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():582-6. PubMed ID: 16279705
    [No Abstract]   [Full Text] [Related]  

  • 18. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors.
    Le Roith D
    N Engl J Med; 1997 Feb; 336(9):633-40. PubMed ID: 9032050
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin-like growth factors and skeletal growth: possibilities for therapeutic interventions.
    Van Wyk JJ; Smith EP
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4349-54. PubMed ID: 10599687
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular basis of intestinal adaptation: the role of the insulin-like growth factor system.
    Lund PK
    Ann N Y Acad Sci; 1998 Nov; 859():18-36. PubMed ID: 9928367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.